Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
University of Pittsburgh
University of Pittsburgh
Washington University School of Medicine
Centre Oscar Lambret
H. Lee Moffitt Cancer Center and Research Institute
Brigham and Women's Hospital
University Hospital, Strasbourg, France
University of Texas Southwestern Medical Center
Sanford Health
Vanderbilt-Ingram Cancer Center
Vanderbilt-Ingram Cancer Center
Groupe Oncologie Radiotherapie Tete et Cou
University of California, San Francisco
UNC Lineberger Comprehensive Cancer Center
Thomas Jefferson University
Thomas Jefferson University
Thomas Jefferson University
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
University of Chicago
University of Chicago
University of Chicago
Rennes University Hospital
University of Chicago
Yonsei University
University of Kentucky
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute, Egypt
University Hospital Ostrava
Arbeitsgemeinschaft medikamentoese Tumortherapie
Louisiana State University Health Sciences Center Shreveport
Arbeitsgemeinschaft medikamentoese Tumortherapie
King Faisal Specialist Hospital & Research Center
University Hospital, Toulouse
Abramson Cancer Center at Penn Medicine
Washington University School of Medicine
Cancer Research UK
Virginia Commonwealth University
University Hospital, Ghent
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
University Hospital, Ghent
M.D. Anderson Cancer Center
University Hospital, Strasbourg, France